PhD in Molecular Medicine

* ** *

Hayat Al Jaibeji

**** ******* ****, *** **,

Kalamazoo, MI 49009 269-***-**** ***************@*****.*** Summery

A technically skilled scientist, result-driven in the field of molecular medicine and transnational research with verifiable achievements in scientific research work. More than 8 years of experience in medical research in the areas of pharmacology and toxicology, genetics and pharmacogenetics. Education

University of Sharjah

College of Medicine

Sharjah, U.A.E.

Ph.D. in Molecular Medicine and Translational Research 09/2016 – 08/2020 The Molecular Medicine and Transnational Science PhD graduate training program were one of the first established molecular medicine programs in the middle east. This program provides a comprehensive study for the following: Analytical approaches to molecular and cellular synthesis, structure and function, Genetics and gene regulation, Cell communication, and Pathophysiology.

Al-Ain University

College of Medicine

Al-Ain, U.A.E.

Master of Biomedical Science-Pharmacology and Toxicology track 01/2011 – 12/2014 Pharmacology and toxicology Study, the outcome of this program is to be able to demonstrate mastery of cutting-edge research approaches in genetics/genomics and describe, critically evaluate, and apply current theoretical perspectives in genetics. Thesis were dedicated to investigate the pharmacogenetics of Warfarin among Arab Population. Griggs University

Sharjah, U.A.E.

Master of Business Administration-Management Studies 01/2009 – 01/2011 The study plan of this professional degree entitled to learn about the major business disciplines such as marketing and business decision making. Dubai Pharmacy

College

Dubai, U.A.E.

B.Sc. Bachelor of Pharmacy 09/2002 – 09/2007

Professional training of one thousand three hundred and fifty hours at Dubai department of Health and Medical Services.

Work experience

University of Sharjah

Sharjah, U.A.E.

Ph.D. Research 09/2016 – 08/2020

Ph.D. research fellow at the diabetes research group, Sharjah Institute of medical research. Diabetes Research that involved novel genes identifications and related functional studies such as siRNA silencing and the related effect on insulin secretion and production, Gene expression assay, western blot, and cell culture. Pharmacogenetics of anticoagulants and oral antidiabetic drugs and microRNA Study. City University

College of Ajman

Ajman, U.A.E.

Lecturer 01/2015 – 08/2017

Lecturer for different classes such as Biology, Life sciences, Addiction, Critical thinking, environmental science, and academic teaching activity. Evaluating student through exams, assays, and oral presentation. Help in the coordination of general education courses. Ibn Sina Pharmacy

Sharjah, U.A.E.

Pharmacist 08/2007 – 10/2008

• Medication distribution and offer patients consoling on their medication need.

• Maintain accurate of inventory of medication.

Boots Pharmacy

Dubai, U.A.E.

Pharmacist 10/2008 – 04/2009

• Responsible for drug distribution and provide clinical services.

• Work with pharmacy staff to maintain clean customer friendly work place. AXA-Gulf Insurance

Dubai, U.A.E.

Medical Claim Management Executive 04/2009 – 01/2011

• Asses pharmaceutical E-Claims from providers.

• Reimbursement claims assessment and evaluation.

• Give prior authorization before medicine dispensation. 2 of 2

Publications

Genes Genetic Variants of the PLCXD3 Gene Are Associated with Risk of Metabolic 06/2020 Syndrome in the Emirati Population.

Aljaibeji, H., D., Mohammed, A. K., Taneera, J., Sulaiman, N. Genes An Integrative Phenotype Approach Using Phenotypic Characteristic 04/2020 From the UAE National Diabetes Study Identifies HSD14B12 as a Candidate Gene for Obesity and Type 2 Diabetes.

Hachim, M.Y.; Aljaibeji, H.; Hamoudi, R.A.; Hachim, I.Y.; Elemam, N.M.; Mohammed, A.K.; Salehi, A.; Taneera, J.; Sulaiman, N. Pharmacogenomics

and Personalized

Medicine

VKORC1 variants as significant predictors of warfarin does in Emiratis. 12/2019 ZN Al-Mahayri, HS Al Jaibeji, Y Saab, K Soliman, L Al-Gazali, GP Patrinos. Scientific Reports Prediabetes and diabetes prevalence and risk factors comparison 11/2019 between ethnic groups in the United Arab, Emirates. Hamoudi, R., Saheb Sharif-Askari, N., Saheb Sharif-Askari, F., Abusnana, S., Aljaibeji, H., Taneera, J., & Sulaiman, N.

Frontiers in

Endocrinology

Reduced expression of PLCXD3 associates with disruption of glucose 10/2019 sensing and insulin signaling in pancreatic β-cells. S Aljaibeji, AK Mohammed, S Dhaiban, NM Elemam, N Sulaiman. Gene GNAS gene is an important regulator of insulin secretory capacity. 10/2019 J Taneera, S Dhaiban, AK Mohammed, D Mukhopadhyay, H Aljaibeji, … The FASEB Journal Effect of Troglitazone (Tz) and N-Acetyl Cysteine (Nac) Treatment 04/2018 On Beta Cells' Survival, and Insulin Production Under Hyperglycemic Conditions.

MA Eladl, M Al Deen Abdul Hafed Alhuarrat, MAA Sabri, SA Sadeq, H Aljaibeji. Current Molecular

Medicine

Maturity-onset diabetes of the young: an overview with a focus on 09/2017 the middle east.

Taneera, B Mussa, M Saber-Ayad, S Dhaiban, H Aljaibeji, N Sulaiman. Hamdan Medical

Journal

Allele and genotype frequencies of two single nucleotide polymorphisms 01/2016 in the VKORC1 gene that are most important for warfarin treatment among Emiratis.

HS Al-Jaibeji, A John, L Al-Gazali, K Soliman, A Oulhaj, T Katsila, A Brand, ... Human Genomics Success stories in genomic medicine from resource-limited countries. 12/2015 K Mitropoulos, H Al Jaibeji, DA Forero, P Laissue, A Wonkam, Pediatric Neurology Clinical and molecular analysis of a novel COLQ missense mutation causing 07/2014 congenital myasthenic syndrome in Syrian family.

HN Matlik, RM Milhem, IY Saadeldin, HS Al-Jaibeji, L Al-Gazali, BR Ali.

Contact this candidate